Bristol-Myers Squibb to Take Part in Jefferies London Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Jefferies London Healthcare Conference on Wednesday, November 15, 2017, in London. John Elicker, senior vice president, Corporate Affairs and Investor Relations, will answer questions about the company at 10:40 a.m. GMT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005176/en/

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
Tim Power, 609-252-7509
[email protected]
or
Bill Szablewski, 609-252-5894
[email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
• Alithya Strengthens Enterprise Project Portfolio Management Capabilities with Addition of Project Technologies Group
• Flow Capital Announces a US$6.0M Investment in an Integrated Payments Platform